tiprankstipranks
Trending News
More News >
Champions Oncology (CSBR)
:CSBR
US Market
Advertisement

Champions Oncology (CSBR) Technical Analysis

Compare
140 Followers

Technical Sentiment

Overall Consensus
Sell
6Bullish
4Neutral
12Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
2Bearish
Moving Average Consensus
Strong Sell
2Bullish
0Neutral
10Bearish
Champions Oncology’s (CSBR) Moving Averages Convergence Divergence (MACD) indicator is -0.37, suggesting Champions Oncology is a Buy.
Champions Oncology’s (CSBR) 20-Day exponential moving average is 6.99, while Champions Oncology’s (CSBR) share price is $6.38, making it a Sell.
Champions Oncology’s (CSBR) 50-Day exponential moving average is 7.26, while Champions Oncology’s (CSBR) share price is $6.38, making it a Sell.

Champions Oncology (CSBR) Pivot Points

Aug 08, 2025, 11:30 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
5.55
5.78
6.08
6.31
6.61
6.84
7.14
Fibonacci
5.78
5.98
6.11
6.31
6.51
6.63
6.84
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Champions Oncology (CSBR) Moving Averages

Aug 08, 2025, 11:30 AM
Period
Simple
Exponential
MA5
6.34Buy
6.41Buy
MA10
6.51Sell
6.63Sell
MA20
7.34Sell
6.99Sell
MA50
7.23Sell
7.26Sell
MA100
7.48Sell
7.42Sell
MA200
7.52Sell
7.02Sell
Champions Oncology’s (CSBR) 10-Day exponential moving average is 6.63, while Champions Oncology’s (CSBR) share price is $6.38, making it a Sell.
Champions Oncology’s (CSBR) 100-Day exponential moving average is 7.42, while Champions Oncology’s (CSBR) share price is $6.38, making it a Sell.
Champions Oncology’s (CSBR) stock price is $6.38 and Champions Oncology’s (CSBR) 50-day simple moving average is 7.23, creating a Sell signal.
Champions Oncology’s (CSBR) stock price is $6.38 and Champions Oncology’s (CSBR) 100-day simple moving average is 7.48, creating a Sell signal.
Champions Oncology’s (CSBR) stock price is $6.38 and Champions Oncology’s (CSBR) 200-day simple moving average is 7.52, creating a Sell signal.

Champions Oncology (CSBR) Technical Indicators

Aug 08, 2025, 11:30 AM
Name
Value
Implied Action
RSI (14)
39.57
Neutral
STOCH (9,6)
22.60
Neutral
STOCHRSI (14)
17.27
Buy
MACD (12,26)
-0.37
Buy
ADX (14)
19.33
Buy
Williams %R
-78.42
Buy
CCI (14)
-67.74
Neutral
ATR (14)
0.58
-
Ultimate Oscillator
40.36
Neutral
ROC
-17.31
Sell
Champions Oncology’s (CSBR) Relative Strength Index (RSI) is 39.57, creating a Neutral signal.
Champions Oncology’s (CSBR) Trend Strength Indicator (ADX) is 19.33, creating a Buy signal.
Champions Oncology’s (CSBR) Commodity Channel Index (CCI) is -67.74, creating a Neutral signal.
Champions Oncology’s (CSBR) Price Rate of Change (ROC) is -17.31, creating a Sell signal.

FAQ

Is CSBR a Buy, Hold, or Sell?
Based on CSBR’s technical indicators, CSBR is a Sell.
    What is CSBR’s RSI (14)?
    CSBR’s RSI (14) is 39.57, which suggests CSBR is a Neutral.
      What is CSBR’s MACD?
      CSBR’s MACD is -0.37, which suggests CSBR is a Buy.
        What is CSBR’s 5-day moving average?
        CSBR’s 5-day moving average is 6.34, which suggests CSBR is a Buy.
          What is CSBR’s 20-day moving average?
          CSBR 20-day moving average is 7.34, which suggests CSBR is a Sell.
            What is CSBR’s 50-day moving average?
            CSBR’s 50-day moving average is 7.23, which suggests CSBR is a Sell.
              What is CSBR’s 200-day moving average?
              CSBR’s 200-day moving average is 7.52, which suggests CSBR is a Sell.
                What is CSBR’s Williams % R (14)?
                CSBR’s Williams % R (14) is -78.42, which suggests CSBR is a Buy.
                  What is CSBR’s CCI (14)?
                  CSBR’s CCI (14) is -67.74, which suggests CSBR is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis